Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Peptide Schedule Research Team

Weight Loss Peptides

GLP-1 agonists, dual and triple agonists for appetite suppression and metabolic improvement. 21 weight loss peptides with doses, safety grades and both sides of the evidence. 6 are popular this week. Updated Oct 8.

All Weight Loss Peptides(21)

What are weight loss peptides?

Weight loss peptides target your appetite and metabolism at the hormonal level. Most mimic GLP-1, a gut hormone that signals fullness to your brain. Some also activate GIP or glucagon receptors for stronger effects. The field has moved fast since 2021, and you now have 21 options on this page ranging from FDA-approved drugs to early-stage research compounds.

Semaglutide (the active ingredient in Ozempic and Wegovy) carries the deepest evidence base. The STEP 1 trial tracked 1,961 adults and landed on 14.9% mean body weight loss at 68 weeks (PMID 33567185). A higher 7.2 mg dose pushed that to 18.7% in STEP UP (PMID 40961952). The SELECT cardiovascular trial (17,604 participants) confirmed a 20% reduction in major cardiac events, which changed how doctors think about GLP-1 drugs entirely. Semaglutide is FDA-approved for both weight management and type 2 diabetes.

Tirzepatide targets two receptors instead of one (GLP-1 and GIP). The SURMOUNT-1 trial reported 20.9% weight loss at 72 weeks in 2,539 participants (PMID 35658024), the highest of any approved option. Retatrutide goes one step further as a triple agonist (GLP-1, GIP, and glucagon); its Phase 2 data showed 24.2% at 48 weeks (PMID 37366315), and its Phase 3 TRIUMPH-1 trial reported 25.0% at 80 weeks on 12 mg (PMID 42814954).

Not every weight loss peptide works through GLP-1. AOD-9604 is a modified fragment of human growth hormone that targets fat metabolism without affecting blood sugar or growth. 5-Amino-1MQ inhibits the NNMT enzyme, which plays a role in fat cell energy regulation. Both sit in the research-only category with limited human data, but community interest is growing.

Ready to plan a weight loss protocol?

Pick peptides, set doses and preview the schedule. A free account adds dose reminders and calendar sync.

Build a Weight Loss Protocol

Related Resources

Frequently Asked Questions

Semaglutide is the most proven option. It's FDA-approved with clinical trial data showing 15-17% average body weight loss. Tirzepatide may work even better for some people since it targets two receptors. Your choice depends on whether you want an FDA-approved option or are open to newer research compounds.

GLP-1 peptides like Semaglutide and Tirzepatide have been through large-scale clinical trials and carry FDA approval. Common side effects include nausea, especially during dose titration. Less-studied options like Retatrutide have smaller safety datasets. Always check the safety grade and research status on each peptide page.

Most people notice reduced appetite within the first 1-2 weeks. Measurable weight loss typically starts by weeks 4-8. GLP-1 peptides require gradual dose titration over several weeks to minimize nausea, so full effects take 2-3 months to reach.

Some peptides are designed to be combined: CagriSema pairs semaglutide with cagrilintide for enhanced effects. But stacking multiple GLP-1 agonists on your own isn't recommended since they target the same receptor. Use our interaction checker to see which combinations are safe.